ContractTrail

Pharmaceutical and Other Medicinal Products · Public Health Agency of Canada

Pharmaceutical and Other Medicinal Products contracts, Public Health Agency of Canada

Contracts Public Health Agency of Canada filed under object code 1132: who it bought from, how, and for how much.

Total value
$388M
Contracts
62
Median contract
$381K
Non-competitive
37%
of 62 contracts that say how they were awarded

Federal contracts over $10,000, contracts dated Jan 2004 to Sep 2026, each counted once at its latest reported value. Source: Treasury Board proactive publication of contracts, published October 13, 2026.

Top vendors

The vendors with the most contract value here.

VendorContractsTotal
Seqirus Canada Inc2$122M
Emergent Biosolutions Inc6$54.5M
Elusys Therapeutics Inc1$45.7M
Roche Diagnostics1$27.6M
Sanofi Pasteur Limited2$18.5M
Emergent Biodefense Operations1$13M
GlaxoSmithKline Inc.2$7.1M
Natco Pharma (Canada) Inc4$4.3M
Cangene Corporation1$2.3M
McKESSON CANADA13$2.3M
Sandoz Canada Inc3$1.9M
Methapharm Inc.3$1.6M
Regeneron Pharmaceutical, Inc.1$1.5M
Mckesson Specialized Distribution Inc3$894K
Merck Canada Inc1$850K
Adapt Pharma Canada Ltd2$686K
Hoffmann-La Roche Ltd (Pharma Division)1$550K
Apotex Inc.1$497K
Heyl Chemisch - Pharmazeutische2$355K
Rafa Laboratories Ltd1$352K
Emergent BioSolutions Canada Inc.1$156K
Hikma Canada Ltd.1$70K
NORLEANS Technologies Inc.1$23K
Vitazan Herbs And Vitamins Inc.1$13K

Plus 7 contracts ($80.6M) to individuals, sole proprietors and vendors this site does not name. They count in every total above. Why

Largest contracts

DateVendorValue
Apr 2019Seqirus Canada Inc$75,262,635
Mar 2026Seqirus Canada Inc$47,139,750
Feb 2024Elusys Therapeutics Inc$45,712,664
Mar 2026Emergent Biosolutions Inc$34,175,344
Jun 2021Roche Diagnostics$27,634,500
Aug 2022Sanofi Pasteur Limited$18,213,123
Mar 2026Emergent Biodefense Operations$13,038,685
Mar 2021Emergent Biosolutions Inc$11,767,050
Feb 2017Emergent Biosolutions Inc$6,553,686
Oct 2019GlaxoSmithKline Inc.$6,373,928
Dec 2013Cangene Corporation$2,344,980
Nov 2023Natco Pharma (Canada) Inc$2,128,280
Apr 2024Regeneron Pharmaceutical, Inc.$1,548,901
Mar 2020Natco Pharma (Canada) Inc$1,467,644
Mar 2025Emergent Biosolutions Inc$1,430,164
May 2025Sandoz Canada Inc$1,283,583
Jun 2024Methapharm Inc.$1,173,359
Jun 2024Merck Canada Inc$850,040
Mar 2026GlaxoSmithKline Inc.$685,797
Nov 2025Hoffmann-La Roche Ltd (Pharma Division)$550,129

Latest contracts

DateVendorValue
Mar 2026Seqirus Canada Inc$47,139,750
Mar 2026Emergent Biodefense Operations$13,038,685
Mar 2026GlaxoSmithKline Inc.$685,797
Mar 2026Emergent Biosolutions Inc$34,175,344
Jan 2026Mckesson Specialized Distribution Inc$409,800
Nov 2025Hoffmann-La Roche Ltd (Pharma Division)$550,129
May 2025Emergent Biosolutions Inc$396,630
May 2025Sandoz Canada Inc$1,283,583
Mar 2025Emergent Biosolutions Inc$1,430,164
Mar 2025Mckesson Specialized Distribution Inc$84,750
Mar 2025Mckesson Specialized Distribution Inc$399,726
Feb 2025Emergent Biosolutions Inc$151,800
Jan 2025McKESSON CANADA$381,141
Jun 2024Methapharm Inc.$1,173,359
Jun 2024Merck Canada Inc$850,040
Apr 2024Regeneron Pharmaceutical, Inc.$1,548,901
Mar 2024McKESSON CANADA$376,975
Feb 2024Elusys Therapeutics Inc$45,712,664
Nov 2023Natco Pharma (Canada) Inc$2,128,280
Aug 2022Hikma Canada Ltd.$70,201

By year

Contracts by the year they were dated.

YearContractsTotal
20131$2.3M
20141$20.3M
20177$7.6M
20188$1.5M
20198$82.6M
20206$61M
20217$41.2M
20224$18.5M
20231$2.1M
20245$49.7M
20258$4.7M
20266$96.3M

How they were awarded

As the department reported it; older contracts often don't say.

Procurement methodContractsTotal
Non-competitive21$215M
Competitive32$95.7M
Competitive: open bidding7$50M
Advance contract award notice2$26.9M

Goods, services or construction

TypeContractsTotal
Goods62$388M